Works matching IS 0008543X AND DT 2023 AND VI 129 AND IP 14
Results: 23
OCRA encourages fallopian tube removal for women undergoing pelvic surgeries for benign conditions.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2116, doi. 10.1002/cncr.34902
- By:
- Publication type:
- Article
Yale study finds Black patients are more likely to experience uterine cancer testing delays.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2115, doi. 10.1002/cncr.34901
- By:
- Publication type:
- Article
First person profile: Edith Peterson Mitchell, MD: The first female US Air Force brigadier general–physician has dedicated her career to improving cancer disparities.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2114, doi. 10.1002/cncr.34900
- By:
- Publication type:
- Article
Reply to "Impact of obesity surgery on tyrosine kinase inhibitor responses and survival outcomes in patients with chronic myeloid leukemia: Further data are still warranted!".
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2268, doi. 10.1002/cncr.34834
- By:
- Publication type:
- Article
Impact of obesity surgery on tyrosine kinase inhibitor responses and survival outcomes in patients with chronic myeloid leukemia: Further data are still warranted!
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2266, doi. 10.1002/cncr.34833
- By:
- Publication type:
- Article
Intersectional disparities in climate vulnerability and cancer risk.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2122, doi. 10.1002/cncr.34817
- By:
- Publication type:
- Article
The case for adjuvant BRAF‐targeted therapy versus adjuvant anti–PD‐1 therapy for patients with resected, high‐risk melanoma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2117, doi. 10.1002/cncr.34806
- By:
- Publication type:
- Article
A novel prostate cancer subtyping classifier based on luminal and basal phenotypes.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2169, doi. 10.1002/cncr.34790
- By:
- Publication type:
- Article
Long‐term outcomes in patients with chronic lymphocytic leukemia treated with ibrutinib: Focus on hypertension and cardiovascular toxicity.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2192, doi. 10.1002/cncr.34787
- By:
- Publication type:
- Article
Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2245, doi. 10.1002/cncr.34786
- By:
- Publication type:
- Article
Pediatric DDR inhibitor combinations: Are WEE1 there yet?
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2132, doi. 10.1002/cncr.34785
- By:
- Publication type:
- Article
Effects of an educational physical activity intervention in young women with newly diagnosed breast cancer: Findings from the Young and Strong Study.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2135, doi. 10.1002/cncr.34779
- By:
- Publication type:
- Article
Impact of bortezomib‐based versus lenalidomide maintenance therapy on outcomes of patients with high‐risk multiple myeloma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2179, doi. 10.1002/cncr.34778
- By:
- Publication type:
- Article
Geographic diffusion of digital mammography in the United States.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2144, doi. 10.1002/cncr.34774
- By:
- Publication type:
- Article
Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple‐negative breast cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2201, doi. 10.1002/cncr.34773
- By:
- Publication type:
- Article
Prospective assessment of pancreatic ductal adenocarcinoma diagnosis from endoscopic ultrasonography images with the assistance of deep learning.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2214, doi. 10.1002/cncr.34772
- By:
- Publication type:
- Article
Trends in health care spending on kidney cancer in the United States, 1996–2016.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2161, doi. 10.1002/cncr.34770
- By:
- Publication type:
- Article
How social media can help to understand treatment experiences of survivors of rare cancers: Findings from the Granulosa Cell Tumor Survivor Sisters Facebook group member survey.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2224, doi. 10.1002/cncr.34767
- By:
- Publication type:
- Article
Rare disease research powered by empowered patients: solving the zebra puzzle through social media.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2128, doi. 10.1002/cncr.34765
- By:
- Publication type:
- Article
Postprogression treatment of lenvatinib plus PD‐1 inhibitor in advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2235, doi. 10.1002/cncr.34764
- By:
- Publication type:
- Article
Surgical phenotype of patients with peritoneal mesothelioma and a germline mutation.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2152, doi. 10.1002/cncr.34763
- By:
- Publication type:
- Article
Quality of life with cemiplimab plus chemotherapy for first‐line treatment of advanced non–small cell lung cancer: Patient‐reported outcomes from phase 3 EMPOWER‐Lung 3.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2256, doi. 10.1002/cncr.34687
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2107, doi. 10.1002/cncr.33719
- Publication type:
- Article